Ajanta Pharma Promoter Ravi Agrawal Releases 54,796 Shares from Pledge

Ravi Agrawal, trustee of Ravi Agrawal Trust and a promoter of Ajanta Pharma Limited, has disclosed the release of pledge on 54,796 equity shares. The disclosure, made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, cites 'Excess Pledge' as the reason for the release. The shares were released from pledges made to lenders including Deutsche Investments India Pvt Ltd., Bajaj Finance Limited, and INFINA FINANCE LIMITED, with Barclays Securities (India) Private Limited acting as the DP. This action reduces the encumbered shares held by Ravi Agrawal Trust.